Section Arrow
ZBH.NYSE
- Zimmer Biomet Holdings
Quotes are at least 15-min delayed:2026/05/12 04:43 EDT
Pre Market
Last
 79.66
+0.08 (+0.10%)
Bid
75
Ask
91.5
High 79.66 
Low 79.58 
Volume 105 
Regular Hours (Closed)
Last
 79.58
-2.75 (-3.34%)
Day High 
82.395 
Prev. Close
82.33 
1-M High
97.805 
Volume 
2.23M 
Bid
75
Ask
91.5
Day Low
79.12 
Open
82.31 
1-M Low
79.83 
Market Cap 
15.93B 
Currency 美元 
P/E 20.62 
%Yield 1.21 
10-SMA 83.5 
20-SMA 88.78 
50-SMA 90.68 
52-W High 108.29 
52-W Low 79.12 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
3.86/8.97
Enterprise Value
22.86B
Balance Sheet
Book Value Per Share
65.51
Cash Flow
Cash Flow Yield
0.10
Income Statement
Total Revenue
8.23B
Operating Revenue Per Share
37.63
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
WOKWORK Medical Technology Group LTD.3.92+2.64+206.25%-- 
Pre Market 1.98 -1.94 -49.49%
BSXBoston Scientific Corp53.37-0.56-1.04%22.33PE
Pre Market 53.43 +0.06 +0.11%
ABTAbbott Laboratories82.56-1.76-2.09%23.13PE
Pre Market 82.71 +0.15 +0.18%
MDTMedtronic plc74.54-1.61-2.11%20.82PE
Pre Market 74.78 +0.24 +0.32%
GEHCGE HealthCare Technologies61.7-1.77-2.79%14.8PE
Pre Market 61.73 +0.03 +0.05%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.